All stock lists
Comstock Resources Inc (New York Stock Exchange:CRK)
US · Delayed Price · Currency is USD
Energy · Oil & Gas Exploration & Production
$14.94-$0.13 (-0.86%)
Market cap
$4.39B
Insider Score
Health Score
Analyst consensus
Listed since
Aug 28, 1987
Website
Insider Score
––Not scored
CRK Insider Score
Insiders here have filed 6 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
CRK analyst forecast
CRK analyst consensus
Hold6 ratings
Buy 0 Hold 4 Sell 2
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
CRK 12-month price target
$14.80-1.2% downsideaverage of 5 firms
$20.00High
$13.00Low
Best analysts covering CRK
- UBS100%success rate · +29.1% avg return · 4 calls
- Piper Sandler71%success rate · +21.7% avg return · 7 calls
- Goldman Sachs60%success rate · -35.5% avg return · 5 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CRK analyst ratings
Filters
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Truist Securities | Hold | — | — | Reiterated | 2026-11-06 |
| Mizuho | Neutral | $20.00 | +26.0% | Reiterated | 2026-10-16 | |
| Morgan Stanley | Equal Weight | $13.00 | -3.8% | Reiterated | 2026-10-15 | |
| Jefferies | — | $14.00 | +1.3% | Price target | 2026-09-25 | |
| UBS | Sell | $13.00 | -10.3% | Reiterated | 2026-09-09 | |
| — | Goldman Sachs | Sell | — | — | Reiterated | 2026-09-02 |
| — | BMO Capital | Market Perform | — | — | Reiterated | 2026-09-02 |
| Roth Capital | — | $14.00 | -12.7% | Price target | 2026-09-01 | |
| Morgan Stanley | Equal Weight | $15.00 | +8.9% | Reiterated | 2026-08-19 | |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-07-20 |
| Roth Capital | Sell | $13.00 | +0.0% | Price target | 2026-07-10 | |
| Morgan Stanley | Equal Weight | $16.00 | +11.9% | Reiterated | 2026-06-29 | |
| Mizuho | Neutral | $21.00 | +9.3% | Reiterated | 2026-05-27 | |
| Morgan Stanley | Equal Weight | $18.00 | +32.1% | Reiterated | 2026-05-22 | |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-01-23 |
| — | B of A Securities | Neutral | — | — | Downgraded | 2026-01-16 |
| UBS | Sell | $20.00 | -11.8% | Reiterated | 2025-12-12 | |
| — | Piper Sandler | Underweight | — | — | Reiterated | 2025-11-18 |
CRK earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-11 | $0.11 | $0.16 | $505.9M | $789.8M |
| 2026-05-05 | $0.23 | $0.15 | $554.0M | $587.4M |
| 2026-07-29 | $0.02 | $0.03 | $419.2M | $353.3M |
| 2026-11-04 | $0.04 | $0.02 | $421.0M | $384.4M |
| 2027-02-10Upcoming | $0.08 | — | $464.2M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.